It has been structurally modified to resist dipeptidyl peptidase-4 (DPP-4) degradation and to enhance albumin binding, extending its half-life to approximately 165 hours
The following GLP-1 medications are FDA-approved for use in the United States: Liraglutide (Saxenda, Victoza) For type 2 diabetes and for long-term weight management in adults and some adolescents with obesity or overweight along with at least one weight-related condition
Trulicity is also a once- weekly GLP-1 agonist that is ready-to-use without reconstitution in the same way that once- daily GLP-1 agonists already are
By activating telomerase, Epithalon may help maintain telomere length, potentially slowing cellular aging
Injection of unverified, unsterile compounds carries infection and inflammatory risks that are independent of any effects the peptide itself might or might not have
As of 2024, Colorado had an obesity rate of 25%